SCHEMBL20138731

SCHEMBL20138731

CN1[N]C(=O)N(C)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2601688 0.61
SCHEMBL735080 0.60
SCHEMBL16660165 0.57
SCHEMBL133474 0.56 GSK3A (0.39)
SCHEMBL2206771 0.54
SCHEMBL6850987 0.54 GSK3A (0.44)
SCHEMBL4409585 0.53 GSK3A (0.32)
SCHEMBL10483659 0.53
SCHEMBL14965051 0.53
SCHEMBL530530 0.52 CASP3 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109890793-B Novel anthelmintic quinoline-3-carboxamide derivatives 拜耳动物保健有限责任公司 2022-11-18 CN disclosed
CN-114423749-A Isoquinoline derivatives and their use for the treatment of parasitic infections 拜耳动物保健有限责任公司 2022-04-29 CN disclosed
EP-3538512-A1 NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES Bayer Animal Health GmbH (DE) 2019-09-18 EP disclosed
WO-2018087036-A1 NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2018-05-17 WO disclosed